⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 15, 2024Open Access

Suppl Table S10 from Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia

Rucha V. Modak Katia G. de Oliveira Rebola John McClatchy Mona Mohammadhosseini Alisa Damnernsawad Stephen E. Kurtz Christopher A. Eide Guanming Wu Ted Laderas Tamilla Nechiporuk Marina Gritsenko Joshua Hansen Chelsea Hutchinson Sara J.C. Gosline Paul Piehowski Daniel Bottomly Nicholas J. Short Karin Rodland Shannon K. McWeeney Jeffrey Tyner Anupriya Agarwal

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

CRISPR pathway enrichment analysis

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Modak et al. (2024) studied this question.

synapsesocial.com/papers/68e6a14db6db643587624f9a https://doi.org/10.1158/1078-0432.25826390.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Suppl Table S10 from Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia2024
2Supp Table S3 from Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia2024
3Supp Table S3 from Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia2024
4Suppl Table S5 from Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia2024
5Suppl Table S5 from Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia2024